UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in VIR — Vir Biotechnology, Inc.
CIK 861177
NEW YORK, NY
Position in VIR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,672,656
+$503,350 QoQ
Shares Held
164,147
+25.8% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 237 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 38%
Shared 0%
None 62%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. VIR ranks #106 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in VIR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,672,656 | 164,147 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,169,306 | 130,503 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $730,110 | 121,080 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $821,884 | 143,938 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,483,685 | 294,383 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,289,924 | 199,063 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,330,922 | 181,325 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,051,377 | 140,371 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,517,972 | 170,559 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $932,556 | 92,059 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $926,111 | 92,059 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $753,478 | 80,414 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,189,129 | 89,243 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,076,682 | 89,243 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,815,864 | 71,745 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,219,091 | 63,231 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,001,074 | 78,566 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,735,584 | 67,480 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,723,306 | 65,042 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,773,050 | 63,719 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,986,677 | 63,170 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $515,724 | 10,059 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $269,380 | 10,059 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $4,403,096 | 128,258 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $6,139,640 | 149,857 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||